These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1562724

  • 1. Constitutive expression of p53 protein in enriched normal human marrow blast cell populations.
    Rivas CI, Wisniewski D, Strife A, Perez A, Lambek C, Bruno S, Darzynkiewicz Z, Clarkson B.
    Blood; 1992 Apr 15; 79(8):1982-6. PubMed ID: 1562724
    [Abstract] [Full Text] [Related]

  • 2. Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics.
    Zhu YM, Bradbury D, Russell N.
    Br J Cancer; 1993 Nov 15; 68(5):851-5. PubMed ID: 8217600
    [Abstract] [Full Text] [Related]

  • 3. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.
    Zhu YM, Bradbury DA, Russell NH.
    Br J Cancer; 1994 Mar 15; 69(3):468-72. PubMed ID: 8123475
    [Abstract] [Full Text] [Related]

  • 4. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
    Lepelley P, Preudhomme C, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P.
    Leukemia; 1994 Aug 15; 8(8):1342-9. PubMed ID: 8057671
    [Abstract] [Full Text] [Related]

  • 5. Altered expression of p53 and MDM2 proteins in hematological malignancies.
    Koníková E, Kusenda J.
    Neoplasma; 2003 Aug 15; 50(1):31-40. PubMed ID: 12687276
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of p53 protein in human leukemia cells.
    Koeffler HP, Miller C, Nicolson MA, Ranyard J, Bosselman RA.
    Proc Natl Acad Sci U S A; 1986 Jun 15; 83(11):4035-9. PubMed ID: 3012545
    [Abstract] [Full Text] [Related]

  • 7. A new acute leukemia-associated blast cell antigen detected by a monoclonal antibody.
    Billing R, Lucero K, Shi BJ, Terasaki PI.
    Blood; 1982 Jun 15; 59(6):1203-6. PubMed ID: 7082823
    [Abstract] [Full Text] [Related]

  • 8. Mutation of the p53 gene in human acute myelogenous leukemia.
    Slingerland JM, Minden MD, Benchimol S.
    Blood; 1991 Apr 01; 77(7):1500-7. PubMed ID: 2009369
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
    Xu L, Chen YT, Huvos AG, Zlotolow IM, Rettig WJ, Old LJ, Garin-Chesa P.
    Diagn Mol Pathol; 1994 Jun 01; 3(2):83-92. PubMed ID: 8061893
    [Abstract] [Full Text] [Related]

  • 10. p53-binding proteins in squamous cell carcinoma and normal human keratinocytes.
    Kumar MG, Spandau DF.
    Cell Growth Differ; 1995 Dec 01; 6(12):1601-8. PubMed ID: 9019165
    [Abstract] [Full Text] [Related]

  • 11. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A, Baumgartner C, Forster HK, Imbach P, Wagner HP.
    Cancer Res; 1983 Sep 01; 43(9):4483-5. PubMed ID: 6603266
    [Abstract] [Full Text] [Related]

  • 12. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia.
    Danova M, Giordano M, Mazzini G, Riccardi A.
    Leuk Res; 1990 Sep 01; 14(5):417-22. PubMed ID: 2140591
    [Abstract] [Full Text] [Related]

  • 13. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone.
    Ueda Y, Dockhorn-Dworniczak B, Blasius S, Mellin W, Wuisman P, Böcker W, Roessner A.
    J Cancer Res Clin Oncol; 1993 Sep 01; 119(3):172-8. PubMed ID: 8418091
    [Abstract] [Full Text] [Related]

  • 14. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T, Morio T, Tohda S, Nagata K, Yamashita Y, Imai Y, Aoki N, Hirashima K, Nara N.
    Jpn J Cancer Res; 1990 Oct 01; 81(10):979-86. PubMed ID: 1699919
    [Abstract] [Full Text] [Related]

  • 15. Human p53 expressed in baculovirus-infected Sf9 cells displays a two-dimensional isoform pattern identical to wild-type p53 from human cells.
    Patterson RM, He C, Selkirk JK, Merrick BA.
    Arch Biochem Biophys; 1996 Jun 01; 330(1):71-9. PubMed ID: 8651706
    [Abstract] [Full Text] [Related]

  • 16. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
    Weidmann E, Brieger J, Jahn B, Hoelzer D, Bergmann L, Mitrou PS.
    Ann Hematol; 1995 Mar 01; 70(3):153-8. PubMed ID: 7718644
    [Abstract] [Full Text] [Related]

  • 17. Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells.
    Zhang W, Hu G, Estey E, Hester J, Deisseroth A.
    Oncogene; 1992 Aug 01; 7(8):1645-7. PubMed ID: 1630824
    [Abstract] [Full Text] [Related]

  • 18. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM, Myers DE, Ledbetter JA, Swaim SE, Gajl-Peczalska KJ, Vallera DA.
    J Immunol; 1988 Mar 15; 140(6):2103-11. PubMed ID: 3126241
    [Abstract] [Full Text] [Related]

  • 19. p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis.
    Orazi A, Kahsai M, John K, Neiman RS.
    Mod Pathol; 1996 Jan 15; 9(1):48-52. PubMed ID: 8821956
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D, Strife A, Arlin Z, Knowles R, Lambek C, Gulati S, McHendry B, McKenzie S, Clarkson B.
    Leukemia; 1989 Jun 15; 3(6):446-52. PubMed ID: 2657231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.